- Home
- RC vs CYRX Comparison
RC vs CYRX Comparison
Compare RC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RC | CYRX |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | 475 | 1100 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.9M | 421.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | RC | CYRX |
|---|---|---|
| Price | $2.08 | $8.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $2.81 | ★ $12.94 |
| AVG Volume (30 Days) | ★ 2.6M | 335.7K |
| Earning Date | 01-01-0001 | 06-04-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | ★ $228,385,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | $67.36 | $9.56 |
| P/E Ratio | ★ N/A | $5.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.55 | $4.63 |
| 52 Week High | $5.48 | $11.45 |
Technical Indicators
Market Signals| Indicator | RC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.24 | 41.99 |
| Support Level | $2.03 | $8.16 |
| Resistance Level | $2.42 | $8.45 |
| Average True Range (ATR) | 0.14 | 0.50 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 87.50 | 44.57 |
Price Performance
Historical ComparisonAbout RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.